Literature DB >> 30049750

Regional thalamic MRI as a marker of widespread cortical pathology and progressive frontotemporal involvement in amyotrophic lateral sclerosis.

Sicong Tu1,2,3, Ricarda A L Menke2,3, Kevin Talbot3, Matthew C Kiernan4, Martin R Turner5,3.   

Abstract

BACKGROUND: The thalamus is a major neural hub, with selective connections to virtually all cortical regions of the brain. The multisystem neurodegenerative syndrome amyotrophic lateral sclerosis (ALS) has pathogenic overlap with frontotemporal dementia, and objective in vivo markers of extra-motor pathological spread are lacking. To better consider the role of the thalamus in neurodegeneration, the present study assessed the integrity of the thalamus and its connectivity to major cortical regions of the brain in a longitudinal manner.
METHODS: Diffusion-based MRI tractography was used to parcellate the thalamus into distinct regions based on structural thalamo-cortical connectivity in 20 patients with ALS, half of whom were scanned at two time points, and 31 matched controls scanned on a single occasion.
RESULTS: At baseline, widespread diffusivity alterations in motor- and extramotor-associated thalamic parcellations were detectable. Longitudinal decline selectively affected thalamic regions associated with frontal and temporal lobe connectivity. Diffusivity measures were significantly correlated with clinical measures of disease burden. Progression of functional disability, as indicated by change on the ALS functional rating scale, was associated with longitudinal change in mean diffusivity of the right frontal lobe thalamic parcellation (r=0.59, p=0.05).
CONCLUSIONS: Regional thalamic connectivity changes mirror the progressive frontotemporal cortical involvement associated with the motor functional decline in ALS. Longitudinal MRI thalamic parcellation has potential as a non-invasive surrogate marker of cortical dysfunction in ALS. © Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  amyotrophic lateral sclerosis; diffusion tensor imaging; motor neuron disease; thalamus; tractography

Mesh:

Substances:

Year:  2018        PMID: 30049750     DOI: 10.1136/jnnp-2018-318625

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  14 in total

1.  Speech network regional involvement in bulbar ALS: a multimodal structural MRI study.

Authors:  Sanjana Shellikeri; Matthew Myers; Sandra E Black; Agessandro Abrahao; Lorne Zinman; Yana Yunusova
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2019-05-14       Impact factor: 4.092

Review 2.  Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis.

Authors:  Colin J Mahoney; Rebekah M Ahmed; William Huynh; Sicong Tu; Jonathan D Rohrer; Richard S Bedlack; Orla Hardiman; Matthew C Kiernan
Journal:  CNS Drugs       Date:  2021-05-15       Impact factor: 5.749

3.  Drug Repurposing: A Network-based Approach to Amyotrophic Lateral Sclerosis.

Authors:  Giulia Fiscon; Federica Conte; Susanna Amadio; Cinzia Volonté; Paola Paci
Journal:  Neurotherapeutics       Date:  2021-05-13       Impact factor: 6.088

Review 4.  Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis.

Authors:  Stephen A Goutman; Orla Hardiman; Ammar Al-Chalabi; Adriano Chió; Masha G Savelieff; Matthew C Kiernan; Eva L Feldman
Journal:  Lancet Neurol       Date:  2022-03-22       Impact factor: 59.935

5.  Amyotrophic Lateral Sclerosis-Frontotemporal Dementia: Shared and Divergent Neural Correlates Across the Clinical Spectrum.

Authors:  Camilla Cividini; Silvia Basaia; Edoardo G Spinelli; Elisa Canu; Veronica Castelnovo; Nilo Riva; Giordano Cecchetti; Francesca Caso; Giuseppe Magnani; Andrea Falini; Massimo Filippi; Federica Agosta
Journal:  Neurology       Date:  2021-12-01       Impact factor: 9.910

6.  Tackling clinical heterogeneity across the amyotrophic lateral sclerosis-frontotemporal dementia spectrum using a transdiagnostic approach.

Authors:  Rebekah M Ahmed; Martina Bocchetta; Emily G Todd; Nga Yan Tse; Emma M Devenney; Sicong Tu; Jashelle Caga; John R Hodges; Glenda M Halliday; Muireann Irish; Matthew C Kiernan; Olivier Piguet; Jonathan D Rohrer
Journal:  Brain Commun       Date:  2021-10-23

Review 7.  Feature selection from magnetic resonance imaging data in ALS: a systematic review.

Authors:  Thomas D Kocar; Hans-Peter Müller; Albert C Ludolph; Jan Kassubek
Journal:  Ther Adv Chronic Dis       Date:  2021-10-13       Impact factor: 5.091

8.  A rare CACNA1H variant associated with amyotrophic lateral sclerosis causes complete loss of Cav3.2 T-type channel activity.

Authors:  Robin N Stringer; Bohumila Jurkovicova-Tarabova; Sun Huang; Omid Haji-Ghassemi; Romane Idoux; Anna Liashenko; Ivana A Souza; Yuriy Rzhepetskyy; Lubica Lacinova; Filip Van Petegem; Gerald W Zamponi; Roger Pamphlett; Norbert Weiss
Journal:  Mol Brain       Date:  2020-03-06       Impact factor: 4.041

9.  Brainstem Involvement in Amyotrophic Lateral Sclerosis: A Combined Structural and Diffusion Tensor MRI Analysis.

Authors:  Haining Li; Qiuli Zhang; Qianqian Duan; Jiaoting Jin; Fangfang Hu; Jingxia Dang; Ming Zhang
Journal:  Front Neurosci       Date:  2021-06-02       Impact factor: 4.677

10.  Neural mechanisms of psychosis vulnerability and perceptual abnormalities in the ALS-FTD spectrum.

Authors:  Emma M Devenney; Sicong Tu; Jashelle Caga; Rebekah M Ahmed; Eleanor Ramsey; Margie Zoing; John Kwok; Glenda M Halliday; Olivier Piguet; John R Hodges; Matthew C Kiernan
Journal:  Ann Clin Transl Neurol       Date:  2021-06-22       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.